A National Cancer Institute-designated Comprehensive Cancer Center

Make an appointment: 800-826-HOPE
Industry Licensing Information Bookmark and Share

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Industry Licensing Information

Partner with City of Hope

City of Hope’s primary interest is caring for and healing our patients.  To accomplish this goal, our researchers and clinicians are continuing to push the science of medicine forward. The Office of Technology Licensing assists in this process by facilitating partnerships with companies whose resources and commercial expertise help translate these basic discoveries into commercial products so they may one day be available to the public and improve the health and prosperity of our patients.

Below is a brief overview of some facts and statistics about City of Hope:
 
  • National Cancer Institute-designated comprehensive cancer center; ranked as a best cancer hospital by U.S.News & World Report
     
  • Translationally focused research institute with core areas of research in oncology, HIV/AIDS and diabetes
     
  • 38 active and 9 pending City of Hope investigational new drugs with the Food and Drug Administration
     
  • 300 ongoing clinical trials
     
  • 100 principal investigators
     
  • $323 million in research grants and royalties

Please contact the OTL team to inquire further about any available technologies or to simply learn more about City of Hope.
 

Featured Technology

Featured Technology

 
Researchers have designed a mobile phone app that enables patients to improve their self management of diabetes via food and lifestyle choices. Learn more.
 
 
Previously Featured Technology
 
 
Licensing Opportunities
 
City of Hope has developed a range of new technologies many of which are available for licensing to established or startup companies.  Almost all of City of Hope's new technologies fall within the fields of Biotechnology, Pharmaceuticals, Diagnostics or Medical Devices.
 
Please browse the available technologies below:
 
 

Antibodies

Anti-Virals and Vaccines

Cell Base Therapies

Diagnostics

Disease Models

Gene Therapies

Medical Devices

Peptides and Aptamers

siRNA

Small Molecules

Overview
Office of Technology Licensing
City of Hope
1500 E. Duarte Rd.
Modular 101
Duarte, CA 91010
 
 
 
Center for Applied Technology Development (CATD)
The Sylvia R. and Isador A. Deutch Center for Applied Technology Development (CATD) offers broad expertise in technology transfer and licensing, biologics manufacturing, quality assurance and regulatory affairs.

City of Hope Campus Map
 
 
 
 
City of Hope is one of only 41 Comprehensive Cancer Centers in the country, the highest designation awarded by the National Cancer Institute to institutions that lead the way in cancer research, treatment, prevention and professional education.
Beckman Research Institute of City of Hope is internationally  recognized for its innovative biomedical research.
Learn more about City of Hope's institutional distinctions, breakthrough innovations and collaborations.


NEWS & UPDATES
  • The physical side effects of cancer can damage anyone’s self-confidence, but especially that of women who, rightly or wrongly, are more likely to find their appearance (or their own perception of their appearance) directly connected to their ability to face the world with something resembling ap...
  • The promise of stem cell therapy has long been studied in laboratories. Now, as medicine enters an era in which this therapy will be increasingly available to patients, the nurses who help deliver it will be in the spotlight. City of Hope, which has launched its Alpha Clinic for Cell Therapy and Innovation (ACT...
  • Just because you can treat a condition, such as high cholesterol, at the end of life — well, that doesn’t mean you should. That’s the basic lesson of a study to be published March 30 in JAMA Internal Medicine. The ramifications go far beyond that. The research, in which City of Hope’s Betty Fe...
  • The understanding of the relationship between genetics and cancer risk continues to grow, with more genetic testing than ever before available to patients. However, the adage that a little knowledge is a dangerous thing is applicable: Without context for what a test result means, and without meaningful guidance...
  • Standard prostate biopsies haven’t changed significantly in the past 30 years – nor have the problems inherent with them. Regular biopsies have an expected error rate: Tumors may potentially be undersampled and, 30 percent of the time, men who undergo a radical prostatectomy are found to have more aggress...
  • In the field of cancer, patients have had surgery, chemotherapy and radiation therapy as options. Now, as City of Hope officially opens the Alpha Clinic for Cellular Therapy and Innovation, patients battling cancer and other life-threatening diseases have another option: stem-cell-based therapy. The Alpha Clini...
  • How does the environment affect our health? Specifically, how does it affect our risk of cancer? City of Hope physicians and researchers recently answered those questions in an Ask the Experts event in Corona, California, explaining the underlying facts about how the environment can affect our health. Moderator...
  • Nurses and other medical professionals have come to understand that it’s not enough just to fight disease. They also must provide pain relief, symptom control, and an unrelenting commitment to improve patients’ quality of life — especially at the end of life. Not too long ago, this was a relatively ...
  • “Tonight, I’m launching a new precision medicine initiative to bring us closer to curing diseases like cancer.” These were the words of President Barack Obama on Jan. 20, 2015, during his State of the Union address. So what is precision medicine, and how close are we to making it a reality for...
  • March is Colon Cancer Awareness Month. How sad, yet how serendipitous, that the co-creator of “The Simpsons” Sam Simon passed away in March after a four-year battle against colon cancer. What message can we all learn from his illness that can help us prevent and overcome colon cancer in our own lives? Colon can...
  • Misagh Karimi, M.D., assistant clinical professor, is a medical oncologist at one of City of Hope’s newest community practice locations, located in Corona in Riverside County. A recent community health report from Corona’s public health department stated that obesity rates for teens and adults in Riverside Coun...
  • In 1975, the median survival for patients with ovarian cancer was about 12 months. Today, the median survival is more than 5 years. Although researchers and clinicians are far from satisfied, the progress in ovarian cancer treatment is encouraging, said Robert Morgan, M.D., F.A.C.P., professor of medical oncolo...
  • Colorectal cancer may be one of the most common cancers in both men and women, but it’s also one of the most curable cancers. Today, because of effective screening tests and more advanced treatment options, there are more than 1 million survivors of colorectal cancer in the United States. Here, colorectal...
  • Breast cancer treatment can damage a woman’s ability to become pregnant, making the impact on fertility one of the key factors that many consider when choosing a therapy regimen. Now a study has found that breast cancer patients treated with a hormone-blocking drug in addition to chemotherapy were less li...
  • My colleagues in the clinic know I’ve got a soft spot. Last week, a patient of mine offered me a fantastic compliment. “You’re looking younger these days, Dr. Pal!” she said, offering me a big hug as she proceeded out of the clinic room. Lovely, I thought. The early morning workouts are paying off. She continue...